Risk of premature menopause after treatment for Hodgkin's lymphoma

Journal of the National Cancer Institute

Volumn 106, Issue 9, 2014, Pages

  Swerdlow, Anthony J ^a   Cooke, Rosie ^a   Bates, Andrew ⁿ   Cunningham, David ^c   Falk, Stephen J ⁱ   Gilson, Dianne ^g   Hancock, Barry W ^k   Harris, Sarah J ^l   Horwich, Alan ^a   Hoskin, Peter J ^f   Linch, David C ^m   Lister, Andrew ^e   Lucraft, Helen H ^h   Radford, John ^b   Stevens, Andrea M ^o   Syndikus, Isabel ^d   Williams, Michael V ^j  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

^e ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^f MOUNT VERNON HOSPITAL   (United Kingdom)

^g St James's Institute of Oncology   (United Kingdom)

^h FREEMAN HOSPITAL   (United Kingdom)

ⁱ BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

^j ADDENBROOKE S HOSPITAL   (United Kingdom)

^k WESTON PARK HOSPITAL   (United Kingdom)

^l GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^m UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

ⁿ SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^o QUEEN ELIZABETH HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE; CHLOROETHYLNITROSOUREA; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; MELPHALAN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CARMUSTINE;

ADULT; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; EARLY MENOPAUSE; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REVIEW; RISK ASSESSMENT; STEM CELL TRANSPLANTATION; ADOLESCENT; CHILD; ENGLAND; EPIDEMIOLOGY; INFANT; OVARY; POISSON DISTRIBUTION; PRESCHOOL CHILD; QUESTIONNAIRE; RADIATION RESPONSE; RADIOTHERAPY DOSAGE; WALES; YOUNG ADULT;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARMUSTINE; CHILD; CHILD, PRESCHOOL; CYTARABINE; DACARBAZINE; DOXORUBICIN; ENGLAND; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; INFANT; MELPHALAN; MENOPAUSE, PREMATURE; OVARY; POISSON DISTRIBUTION; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; RISK ASSESSMENT; SURVEYS AND QUESTIONNAIRES; VINBLASTINE; WALES; YOUNG ADULT;

EID: 84927603243     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju207     Document Type: Review

References (29)

1. Kannel WB, Hjortland MC, McNamara PM, et al. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med. 1976;85(4):447-452.
2. De Kleijn MJ, Van Der Schouw YT, Verbeek AL, et al. Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol. 2002;155(4):339-345.
3. Lindquist O, Bengtsson C, Hansson T, et al. Age at menopause and its relation to osteoporosis. Maturitas. 1979;1(3):175-181.
4. Vega EM, Egea MA, Mautalen CA. Influence of the menopausal age on the severity of osteoporosis in women with vertebral fractures. Maturitas. 1994;19(2):117-124.
5. Lisabeth LD, Beiser AS, Brown DL, et al. Age at natural menopause and risk of ischemic stroke: the Framingham heart study. Stroke. 2009;40(4):1044-1049.
6. Van Leeuwen FE, Klokman WJ, Stovall M, et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst. 2003;95(13):971-980.
7. Byrne J, Fears TR, Gail MH, et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol. 1992;166(3):788-793.
8. Sklar CA, Mertens AC, Mitby P, et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst. 2006;98(13):890-896.
9. De Bruin ML, Huisbrink J, Hauptmann M, et al. Treatment-related risk factors for premature menopause following Hodgkin lymphoma. Blood. 2008;111(1):101-108.
10. Chiarelli AM, Marrett LD, Darlington G. Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964-1988 in Ontario, Canada. Am J Epidemiol. 1999;150(3):245-254.
11. Swerdlow AJ, Cooke R, Bates A, et al. Breast Cancer Risk After Supradiaphragmatic Radiotherapy for Hodgkin's Lymphoma in England and Wales: A National Cohort Study. J Clin Oncol. 2012;30(22):2745-2752.
12. Cox DR. Regression models and life-tables (with Discussion). J R Stat Soc. 1972; B34:187-220.
13. Morris DH, Jones ME, Schoemaker MJ, et al. Body mass index, exercise, and other lifestyle factors in relation to age at natural menopause: analyses from the Breakthrough Generations Study. Am J Epidemiol. 2012;175(10):998-1005.
14. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702-706.
15. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: John Wiley & Sons; 1980.
16. StataCorp. Stata Statistical Software: Release 10. 2007. College Station, TX, Stata Corporation.
17. Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 2009;30(5):465-493.
18. Clark ST, Radford JA, Crowther D, et al. Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen. J Clin Oncol. 1995;13(1):134-139.
19. Behringer K, Breuer K, Reineke T, et al. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol. 2005;23(30):7555-7564.
20. Hodgson DC, Pintilie M, Gitterman L, et al. Fertility among female Hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy. Hematol Oncol. 2007;25(1):11-15.
21. Choo YC, Chan SY, Wong LC, et al. Ovarian dysfunction in patients with gestational trophoblastic neoplasia treated with short intensive courses of etoposide (VP-16-213). Cancer. 1985;55(10):2348-2352.
22. Larsen EC, Muller J, Schmiegelow K, et al. Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab. 2003;88(11):5307-5314.
23. Nicosia SV, Matus-Ridley M, Meadows AT. Gonadal effects of cancer therapy in girls. Cancer. 1985;55(10):2364-2372.
24. Faddy MJ, Gosden RG, Gougeon A, et al. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod. 1992;7(10):1342-1346.
25. Wallace WH, Thomson AB, Saran F, et al. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62(3):738-744.
26. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67(4):604-606.
27. Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500-2510.
28. The Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005;83(6):1622-1628.
29. British Fertility Society. A strategy for fertility services for survivors of childhood cancer. Hum Fertil (Camb). 2003;6(2):A1-A39.